AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-199229206/vertex-promotes-peter-mueller.html" title="Facts and information about Vertex promotes Peter Mueller to EVP of R&D.">Vertex promotes Peter Mueller to EVP of R&D.</a>

Close Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.

Frequently asked questions about RSS feeds

Vertex promotes Peter Mueller to EVP of R&D.

Pharma Marketletter

| May 11, 2009 | COPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The USA's Vertex Pharmaceuticals has promoted executive vice president of drug innovation and realization, Peter Mueller, to EVP of …

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Peter Mueller.(Newsmakers)(named vice president at Vertex Pharmaceuticals...: Magazine article from: Chain Drug Review August 18, 2003 700+ words
Peter Mueller has been chosen senior vice president and chief scientific officer at Vertex Pharmaceuticals Inc. He had held an executive position with Boehringer Ingelheim Pharmaceuticals Inc.


Vertex Pharmaceuticals Announces the Appointment of Dr. Peter Mueller as Chief...: Press release article from: PR Newswire July 21, 2003 700+ words
Vertex Pharmaceuticals Incorporated today announced that it has named Dr. Peter Mueller to the position of Chief Scientific...filed and granted patents. About Vertex Vertex Pharmaceuticals Incorporated is a global biotechnology...


Vertex Pharmaceuticals.(MANUFACTURING): Magazine article from: Medical Marketing & Media June 1, 2009 700+ words
Vertex Pharmaceuticals promoted Peter Mueller to EVP, global R&D chief and chief science officer. The promotion follows Freda Lewis-Hall's move from Vertex to...


Vertex Pharmaceuticals Announces Discovery of Two New Classes of Compounds...: Press release article from: PR Newswire June 9, 2004 700+ words
...Williamsburg Conference Vertex Pharmaceuticals Incorporated today announced...the cell membrane," said Peter Mueller, Ph.D., Chief Scientific...disease." About Vertex Vertex Pharmaceuticals Incorporated is a global...


Vertex Pharmaceuticals Incorporated Strengthens HCV Drug Development Portfolio,...: News wire article from: Fair Disclosure Wire March 3, 2009 700+ words
...everyone to the Vertex Pharmaceuticals conference call...COMMUNICATIONS, VERTEX PHARMACEUTICALS, INC.: Thank...add that Dr. Peter Mueller, our Chief Scientific...DEVELOPMENT, VERTEX PHARMACEUTICALS, INC.: Thank...


Mueller To Head Global R&D At Vertex Pharmaceuticals.: News wire article from: The America's Intelligence Wire May 5, 2009 700+ words
...Head Global R&D At Vertex Pharmaceuticals (C)2009 Investrend Communications...NASDAQ: VRTX) has promoted Peter Mueller, the company's EVP for...Massachusetts-based Vertex Pharmaceuticals is a biotechnology company...


Vertex Promotes Dr. Peter Mueller to Global R&D Chief and Chief Science Officer.: Press release article from: Business Wire May 4, 2009 700+ words
...Mass. -- Vertex Pharmaceuticals Incorporated...that Dr. Peter Mueller, Vertex...President, Vertex Pharmaceuticals Incorporated...said Peter Mueller. Also...Officer, Vertex Pharmaceuticals Incorporated...


Drug discovery company appoints Peter Mueller as chief scientific officer.: Newspaper article from: Biotech Week August 20, 2003 700+ words
...NewsRx.com & NewsRx.net) -- Vertex Pharmaceuticals Inc. has announced that it has named Dr. Peter Mueller to the position of chief scientific...filed and granted patents. Vertex Pharmaceuticals Inc. is a biotechnology company...


Vertex names Peter Mueller CSO and senior VP, drug discovoery.: Newspaper article from: Pharma Marketletter July 28, 2003 700+ words
Peter Mueller, previously with Boehringer Ingelheim, is joining Vertex Pharmaceuticals as chief scientific officer and senior vice president, drug discovery and innovation, and will direct research across Vertex' US and UK sites.


The Boston Globe Biotechnology Briefs Column.: Newspaper article from: Knight Ridder/Tribune Business News July 23, 2003 700+ words
...marketed by Aventis Pharmaceuticals Inc., and Clarinex, sold by Schering-Plough Corp. VERTEX PHARMACEUTICALS INC. has named Peter Mueller, a former executive from Boehringer Ingelheim Pharmaceuticals GmBH, its new chief scientific...

For more facts and information, see all results

Source: HighBeam Research, Vertex promotes Peter Mueller to EVP of R&D.

The AccessMyLibrary advertising network includes: